In a novel approach [77] aimed at overcoming radiotherapy-related treatment resistance by targeting Dyrk1B kinase activity, the specific Dyrk1B inhibitor AZ191 was used with ionizing radiation (IR) to enhance tumor cell killing under stress conditions in SW620 colorectal cancer cells. Here, DYRK1B is linked to colorectal cancer.